FLEET ENEMA EXTRA OTC
Generic Name and Formulations:
Monobasic sodium phosphate 19g, dibasic sodium phosphate 7g; per 197mL; latex-free; contains 4.4g sodium per enema.
Fleet, C.B., Company
Indications for FLEET ENEMA EXTRA:
Occasional constipation or bowel cleansing before rectal exam.
1 enema rectally daily; may be used up to 7 days. Results usually within 1–5mins; re-evaluate if no relief after 7 days.
Use other forms.
Megacolon. Bowel obstruction. Imperforate anus. CHF.
Sodium restricted diet. Impaired renal or cardiac function. Electrolyte disturbances. Colostomy. Discontinue if rectal bleeding or if no bowel movement occurs. Frequent use leads to dependence. Pregnancy. Nursing mothers.
Electrolyte imbalances possible with calcium channel blockers, diuretics; use cautiously.
Original enema—133mL; Extra—230mL
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D